Beyond epilepsies where genetic screening and therapeutic resection surgeries are more common, human genetic validation and patient tissue studies for non-epileptic neurological disorders involving acquired KCC2 hypofunction can be more difficult. Here, SLC12A5 is linked to nervous system disorder.